Armistice Capital’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Armistice Capital’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-38,578	Closed	-$352K	–	407
2024 Q1	$352K	Buy	+38,578	New	+$243K	﹤0.01%	232
2023 Q3	–	Sell	-9,000	Closed	-$480K	–	293
2023 Q2	$480K	Buy	+9,000	New	+$586K	0.01%	167

Armistice Capital's YTEN Position: Q2 2024 in Review

Armistice Capital sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 38,578 shares — an estimated $352K sold.

Armistice Capital first reported a position in YTEN in Q2 2023 and held it in 2 quarters. The position peaked at $480K in Q2 2023. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.

Armistice Capital reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Armistice Capital sold 38,578 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $352K.
Armistice Capital first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Armistice Capital's Yield10 Bioscience, Inc. Common Stock position peaked at $480K in Q2 2023.
0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.